K awasaki syndrome is an acute vasculitis of unknown cause that predominantly occurs in infancy and early childhood. Coronary artery aneurysms or ectasia develop in approximately 15-25% of affected children.1-3 Recently, therapy during the acute phase with intravenous y-globulin has been demonstrated to achieve a fivefold reduction in the prevalence of coronary artery lesions. [4] [5] [6] [7] Although coronary artery abnormalities detectable by echocardiography occur in a minority of patients, the known histopathology of early Kawasaki syndrome8-'2 suggests a more frequent occurrence of subclinical inflammation in the coronary arteries and in other medium-sized muscular arteries. Acute Kawasaki syndrome is also a diffuse vasculitis involving the noncoronary arterioles, venules, and capillaries. Although the inflammatory responses involving the endothelium in the acute phase have been well characterized,13 the extent and persistence of endothelial abnormalities after Kawasaki syndrome are unknown.
The purpose of the present study was to investigate the lipid profiles of children with a history of Kawasaki syndrome. Delineation of the lipid profile is particularly vital in these patients because of the predilection of Kawasaki those for children 5-9 years old. We compared patients with normal subjects using one-sample t tests on z scores. We investigated changes in patient scores over time using repeated measures analysis of variance and Scheffe's method for post-hoc multiple comparisons. We tested whether adjusted (i.e., z scored) plasma lipid concentrations were different in children and their parents using the paired t test.
Results

Demographic Data
Among the 105 patients with Kawasaki syndrome, 67 (63.8%) were male, 14 (13.3%) had coronary artery abnormalities on at least one echocardiogram, and 58 (55.2%) received intravenous y-globulin therapy within the first 10 days of illness. Only nine patients (8.6%) were less than 2 years old, and none was less than 1 year old when their first lipid profile was measured. Only one lipid profile was measured in an adolescent (13 years old). The majority of patients (95; 90%) were Caucasian; six were Black (6%), and four were Asian (4%).
Changes in Lipid Profiles Over Time
We examined changes in plasma lipid concentrations as a function of time since onset of Kawasaki syndrome (see Table 1 ). Plasma total cholesterol concentrations ( Figure 1) were depressed (122.0+ 19.8 mg/dl, mean+SD) during the first 10 days of illness (period 1). Total cholesterol levels during period 1 were significantly lower than during all other periods (p<0.05 by Scheffe's). Plasma cholesterol concentrations rebounded between 10 and 31 days (163.5+25.3 mg/dl) and were not significantly different from normative values after 3 months.
Plasma concentrations of HDL cholesterol ( Figure  2 ) increased significantly with time since disease onset (p=0.0001 by repeated measures analysis of variance). During the first 10 days of illness, HDL cholesterol was profoundly depressed (15.2+9.9 mg/ dl). Mean HDL cholesterol concentration increased sharply (41.5-+±10.4 mg/dl) by the period of 11-31 days. The highest mean concentration (47.2±10.9 mg/dl) was achieved by the sixth period examined (i.e., more than 3 years after disease onset). Even in this interval, adjusted HDL cholesterol values of Kawasaki patients remained significantly lower than normal (p<0.0001). The relation between HDL cholesterol concentration and time since disease onset was not altered when controlled for patient age.
Plasma triglyceride concentrations were extremely high during the first 10 days of illness (162.5-+±63.4 mg/dl, mean±SD), even when considering that they were obtained with subjects in the nonfasting state.
Mean triglyceride concentration declined considerably (119.0+73.9 mg/dl) in the subsequent period (11-31 days). In the sixth period, mean triglyceride concentration was 101.2+47.0 mg/dl; at this time, three of 30 patients (10%) had a plasma triglyceride concentration above the 95th percentile for normal The ratio of total cholesterol to HDL cholesterol was also related to time from disease onset. This ratio was extremely high during the first 10 days of illness (11.6+±6.2). By the next period, 11-31 days, the mean ratio had decreased significantly (p<0.01 by Scheffe's) to 4.2+1.2. Subsequently, the ratio continued to decrease gradually to 3.3+0.9 during the sixth period.
We explored whether the onset of puberty in male patients could account for the persistent depression of HDL cholesterol levels. The average ages of patients in periods 1-5 were similar, with a higher mean age in period 6. No child was more than 10 years old until period 6, when two boys 11 and 13 years old were included in the sample. Thus, it is unlikely that the persistence of low HDL cholesterol could be attributed to the influence of age. 
Comparison of Patients With Their Parents
We compared age-and sex-adjusted plasma total cholesterol and HDL cholesterol levels (i.e., z scores) of 46 patients with those of their parents (Figure 3) . For 
Influence of Severity of Systemic Inflammation
We examined the correlation of serum lipid concentrations measured at least 6 weeks after illness onset with laboratory parameters of systemic inflammation in the subset of patients in whom these data were prospectively gathered from our center as part of a multicenter clinical trial on treatment of Kawasaki syndrome with intravenous y-globulin.5 White blood cell count, absolute band count, and serum concentration of ca1-antitrypsin (reflecting the acute phase response) were measured at the time of enrollment (within 10 days of fever onset) and then 4-6 days, 2 weeks, and 7 weeks after enrollment. The small sample size measured during period 1 limited our power to detect correlations of lipid abnormalities with severity of inflammation during the acute phase. None of these laboratory indexes was significantly associated with plasma lipid concentrations after clinical recovery from the disease.
Inflammations of the liver and gall bladder occur frequently in acute Kawasaki syndrome and might influence serum lipid values. We explored whether abnormalities of liver function were correlated with plasma HDL cholesterol concentration. Only during the first three periods was the number of patients with measurements of both lipid levels and liver function sufficient to perform statistical analyses. HDL cholesterol concentration was inversely correlated with serum alanine amino transferase level during period 1 (p=0.028) but not during periods 2 or 3. The changes in HDL cholesterol between periods 1 and 2 and between periods 2 and 3 were not significantly associated with the concurrent changes in serum alanine amino transferase level.
The severity of systemic vasculitis in acute Kawasaki syndrome is reflected to some extent in the development of coronary artery lesions. [19] [20] [21] [22] We therefore compared the concentrations of HDL cholesterol in children with or without persistent coronary artery abnormalities as detected by two-dimensional echocardiography. In measurements obtained after clinical recovery, HDL cholesterol concentrations of children with coronary artery abnormalities were lower than those of children without such lesions (37.2+ 12.7 versus 44.1+9.9 mg/dl, respectively), but the difference did not achieve statistical significance (p = 0.085).
Influence of Treatment With y-Globulin
We compared plasma lipid concentrations of patients who received treatment with high-dose intravenous y-globulin (1.6 gm/kg) and aspirin with those who were treated with aspirin alone ( Table 2 ). The small number of patients in the aspirin group in periods 1 and 2 precluded comparisons between the treatment groups in these periods. Total cholesterol tended to be higher among patients treated with y-globulin in periods 2-6, but this difference achieved statistical significance only in period 6 (p<0.001). This finding could not be attributed to 122±20 (14) ...
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isolated extreme values in either the aspirin or the y-globulin group, and its explanation is obscure.
Children treated with y-globulin had higher HDL cholesterol levels during period 3 (p=0.068) and period 4 (p = 0.043), consistent with faster recovery in the y-globulin group. Discussion We found that Kawasaki syndrome is associated with significant abnormalities in lipid profile. In the earliest days of illness, mean plasma concentrations of total cholesterol and HDL cholesterol were profoundly depressed, whereas mean triglyceride concentration was very high. Total cholesterol values rapidly returned to normal and remained stable more than 3 months after the onset of illness. HDL cholesterol concentration recovered more slowly after illness onset, and mean HDL cholesterol concentration was significantly lower than expected, even in the period, more than 3 years after illness onset.
The [40] [41] [42] Our findings with regard to total cholesterol and HDL cholesterol are qualitatively similar to those observed in Japanese children by Okada and colleagues. 43 These authors demonstrated a steady increase in HDL cholesterol concentrations after Kawasaki syndrome, with more severe and persistent depression occurring among those with coronary artery lesions. More than 3 years after disease onset, the distribution of HDL cholesterol values was similar among patients with and without coronary abnormalities and those in a small control group. The persistence of a significantly lower mean adjusted HDL cholesterol during a similar late period in our population might reflect our greater sensitivity to detect such a difference using a large-population normative data base. Our data differ from those recently described in an Hawaiian population in which 24% of children studied after clinical recovery had total cholesterol levels greater than the 95th percentile. 44 The discrepancy in total cholesterol values between our New England population and the studied children in Hawaii might be related to differences in local population normative values.
We cannot exclude the possibility that changes in habitual activity or diet after clinical recovery influenced plasma lipid concentrations. Furthermore, we cannot eliminate the possibility that low HDL cholesterol concentration anteceded the onset of Kawasaki syndrome and is a risk factor for its development. The patients in our sample were healthy, normal children before the onset of Kawasaki syndrome and appeared to resume their normal lifestyle after clinical recovery. HDL cholesterol levels improved more rapidly in children treated during the acute phase of Kawasaki syndrome with y-globulin plus aspirin than in those treated with aspirin alone. The faster recovery of lipid abnormalities in y-globulin-treated patients suggests an additional benefit of this therapy for Kawasaki syndrome.
Summary
We found alterations in lipid profile in Kawasaki syndrome that appear to persist long after the clinical resolution of the disease. Further basic research is needed to elucidate the mechanisms by which these abnormalities are produced. Continued long-term surveillance will be necessary to monitor lipid concentrations and their relation to development of coronary artery atherosclerosis in this population.
